Benefits from Long-Term Treatment in Irritable Bowel Syndrome

Figure 3

Mean abdominal pain/discomfort score (a) and bloating score (b) in patients cohort enrolled in retreatment phase with tegaserod. Modified from [8].

(a)

(b)